These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32409974)

  • 1. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
    Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
    Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
    Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
    PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
    Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
    Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma asymmetric dimethylarginine and its association with some of cardiovascular disease risk factors in chronic kidney disease.
    Quoc Hoang TA; Tam V; Thang HV
    Med J Malaysia; 2019 Jun; 74(3):209-214. PubMed ID: 31256175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
    Bartnicki P; Kowalczyk M; Franczyk-Skóra B; Baj Z; Rysz J
    Curr Vasc Pharmacol; 2016; 14(4):360-7. PubMed ID: 26759218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of endothelial dysfunction: the role of symmetrical dimethylarginine and proinflammatory markers in chronic kidney disease and renal transplant recipients.
    Memon L; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Kotur-Stevuljevic J; Simic-Ogrizovic S; Giga V; Dopsaj V; Jelic-Ivanovic Z; Spasic S
    Dis Markers; 2013; 35(3):173-80. PubMed ID: 24167363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
    David S; Kümpers P; Lukasz A; Fliser D; Martens-Lobenhoffer J; Bode-Böger SM; Kliem V; Haller H; Kielstein JT
    Nephrol Dial Transplant; 2010 Aug; 25(8):2571-6. PubMed ID: 20179005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease.
    Nemcsik J; Cseprekál O; Egresits J; Kielstein J; Kümpers P; Lukasz A; Tabák Á; Marton A; Németh ZK; Járai Z; Godina G; Sallai L; Farkas K; Kiss I; Tislér A
    J Hypertens; 2017 May; 35(5):1109-1118. PubMed ID: 28106663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
    Sibal L; Agarwal SC; Schwedhelm E; Lüneburg N; Böger RH; Home PD
    Cardiovasc Diabetol; 2009 Jun; 8():27. PubMed ID: 19486510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity.
    Lilitkarntakul P; Dhaun N; Melville V; Blackwell S; Talwar DK; Liebman B; Asai T; Pollock J; Goddard J; Webb DJ
    Atherosclerosis; 2011 May; 216(1):217-25. PubMed ID: 21376323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study.
    Usui T; Ninomiya T; Nagata M; Takahashi O; Doi Y; Hata J; Fukuhara M; Kitazono T; Oike Y; Kiyohara Y
    Circ J; 2013; 77(9):2311-7. PubMed ID: 23739531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation.
    Sharma J; Kapoor A; Muthu R; Prasad N; Sinha A; Khanna R; Kumar S; Garg N; Tewari S; Sharma RK; Goel P
    Clin Transplant; 2014 Aug; 28(8):889-96. PubMed ID: 24930933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.
    Ardigo D; Stüehlinger M; Franzini L; Valtueña S; Piatti PM; Pachinger O; Reaven GM; Zavaroni I
    Eur J Clin Invest; 2007 Apr; 37(4):263-9. PubMed ID: 17373961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methylarginies-induced endothelial dysfunction in chronic kidney disease].
    Kimura K
    Yakugaku Zasshi; 2012; 132(4):443-8. PubMed ID: 22465920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.